Bristols drug cocktail cuts kidney cancer death risk 37 percent Ruby Khatun Khatun14 Sept 2017 9:25 AM ISTMADRID: A combination of two Bristol-Myers Squibb immunotherapy drugs cut the risk of death by 37 percent in a key group of kidney cancer patients,...
Lupin to add GLP 1 analog to its diabetes portfolio in India Ruby Khatun Khatun13 Sept 2017 3:07 PM ISTMumbai: Lupin plans to introduce a new class of diabetes drugs in India through in-licensing agreements in order to enhance its diabetes drugs...
Glenmark gets USFDA approval for Rythmol SR generic Ruby Khatun Khatun13 Sept 2017 2:08 PM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Rythmol SR capsules, an...
Panacea Biotec extends distribution pact with Canadian firm for US Ruby Khatun Khatun13 Sept 2017 1:43 PM ISTNew Delhi: Drug firm Panacea Biotec on Monday said it has expanded its existing collaboration with Canada's Apotex Inc for sales and distribution of...
AbbVie says deaths in arthritis trial not linked to drug Ruby Khatun Khatun13 Sept 2017 1:42 PM ISTAbbVie Inc said on Monday two patients died in a late-stage trial of its rheumatoid arthritis drug but that the deaths were not linked to the drug,...
Regeneron, Sanofi asthma drug data fails to excite investors Ruby Khatun Khatun13 Sept 2017 1:42 PM ISTPARIS: Shares of Regeneron Inc and Sanofi SA slid on Monday after late-stage trial data for their asthma drug, dupilumab, fell short of investor...
Strides Shasun gets USFDA nod for kidney stone tablets Ruby Khatun Khatun13 Sept 2017 1:41 PM ISTNew Delhi: Strides Shasun on Tuesday said it has received approval from the US health regulator for potassium citrate extended release tablets used to...
Sanofi launches Combiflam Icyhot pain relief topical in India Ruby Khatun Khatun12 Sept 2017 12:35 PM ISTMumbai: Sanofi India on Monday said it has expanded its consumer healthcare portfolio by launching Combiflam Icyhot, a topical analgesic in the...
Novartis posts a win, Roche a flop in skin cancer trials Ruby Khatun Khatun12 Sept 2017 12:30 PM ISTZURICH/MADRID: Swiss drugmaker Novartis notched a trial win for its drug cocktail against skin cancer on Monday, while a rival treatment from Roche...
Lupin gets USFDA nod to market anti-infections tablets Ruby Khatun Khatun12 Sept 2017 10:21 AM ISTNew Delhi: Drug firm Lupin has received approval from the US health regulator to market its generic Doxycycline hyclate tablets, used for the...
Lilly takes on Pfizer, Novartis with new breast cancer drug data Ruby Khatun Khatun12 Sept 2017 10:01 AM ISTNEW YORK/MADRID: Eli Lilly staked its claim for a slice of sales in a new class of breast cancer drugs on Sunday as clinical data showed adding its...
Drugmaker Teva hires Lundbeck CEO Schultz to restore its health Ruby Khatun Khatun12 Sept 2017 9:47 AM ISTJERUSALEM/COPENHAGEN: Teva poached Lundbeck's Kare Schultz as its new chief executive on Monday, handing the drugs industry veteran the urgent task of...
